Literature DB >> 17037607

Identification and evaluation of coronavirus replicase inhibitors using a replicon cell line.

Elke Scandella1, Klara K Eriksson, Tobias Hertzig, Christian Drosten, Lili Chen, Chunshan Gui, Xiaomin Luo, Jianhua Shen, Xu Shen, Stuart G Siddell, Burkhard Ludewig, Hualiang Jiang, Stephan Günther, Volker Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037607      PMCID： PMC7123120          DOI： 10.1007/978-0-387-33012-9_111

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

Review 1.  Virus-encoded proteinases and proteolytic processing in the Nidovirales.

Authors:  J Ziebuhr; E J Snijder; A E Gorbalenya
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

2.  Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus.

Authors:  Volker Thiel; Jens Herold; Barbara Schelle; Stuart G Siddell
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

3.  A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS.

Authors:  B RUBIN; J J PIALA; J C BURKE; B N CRAVER
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-11-01

4.  Clinical and electroencephalographic effects of cinanserin in schizophrenic and manic patients.

Authors:  T M Itil; N Polvan; J M Holden
Journal:  Dis Nerv Syst       Date:  1971-03

5.  Cinanserin (SQ. 10,643): a preliminary evaluation in chronic schizophrenic patients.

Authors:  D M Gallant; M P Bishop
Journal:  Curr Ther Res Clin Exp       Date:  1968-09

6.  Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.

Authors:  Lili Chen; Chunshan Gui; Xiaomin Luo; Qingang Yang; Stephan Günther; Elke Scandella; Christian Drosten; Donglu Bai; Xichang He; Burkhard Ludewig; Jing Chen; Haibin Luo; Yiming Yang; Yifu Yang; Jianping Zou; Volker Thiel; Kaixian Chen; Jianhua Shen; Xu Shen; Hualiang Jiang
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

Authors:  Kanchan Anand; John Ziebuhr; Parvesh Wadhwani; Jeroen R Mesters; Rolf Hilgenfeld
Journal:  Science       Date:  2003-05-13       Impact factor: 47.728

8.  Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.

Authors:  Tobias Hertzig; Elke Scandella; Barbara Schelle; John Ziebuhr; Stuart G Siddell; Burkhard Ludewig; Volker Thiel
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891
  8 in total
  2 in total

1.  Plaque assay for human coronavirus NL63 using human colon carcinoma cells.

Authors:  Petra Herzog; Christian Drosten; Marcel A Müller
Journal:  Virol J       Date:  2008-11-12       Impact factor: 4.099

2.  In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.

Authors:  Seref Gul; Onur Ozcan; Sinan Asar; Alper Okyar; Ibrahim Barıs; Ibrahim Halil Kavakli
Journal:  J Biomol Struct Dyn       Date:  2020-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.